RxDoctor Payments Data

Denise Barnhardt

Medical · Edina, MNNPI 1508898917

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.

$907in general payments, 2019–2025

Across 53 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$128
  • Sanofi$105
  • Incyte Corporation$90
  • Johnson & Johnson$85
  • Bsn Medical Inc$70
  • Regeneron Healthcare Solutions, Inc.$61
  • plus $368 from 13 others

What the payments were for

  • Food & beverage$907100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$907 in reported general payments places this provider in the 80th percentile of 202 medical providers in Minnesota.

See all medical providers in Minnesota

Medicare billing

Part B allowed, 2024
$74,347
Medicare patients
284
Services billed
3,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast31$150,492
Betamethasone Dipropionate106$3,503
Tretinoin28$2,394
Ketoconazole111$1,988
Tacrolimus18$1,883
Fluorouracil20$1,682
Metronidazole33$1,312
Desonide35$1,303
Clindamycin Phosphate26$1,266
Triamcinolone Acetonide45$1,177
Azelaic Acid11$872
Mometasone Furoate36$668
Doxycycline Monohydrate28$664
Clobetasol Propionate30$631
Minocycline Hcl20$558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$50$150,49231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 202 medical providers in Minnesota.

Other medical in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →